Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells
AssigneeDeciduous Therapeutics, Inc.
InventorsMatthew Duncton, Thomas Bobinski, Robin Mansukhani
Life of this patent
Estimating the term…